✦ LIBER ✦

Chromosomal aberrations +1q21 and del(17p13) predict survival in patients with recurrent multiple myeloma treated with lenalidomide and dexamethasone

✍ Scribed by Ulrike Klein; Anna Jauch; Thomas Hielscher; Jens Hillengass; Marc S. Raab; Anja Seckinger; Dirk Hose; Anthony D. Ho; Hartmut Goldschmidt; Kai Neben

Book ID: 102107850
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 250 KB
Volume: 117
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.25775

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effective prophylaxis of thromboembolic

Effective prophylaxis of thromboembolic complications with low molecular weight heparin in relapsed multiple myeloma patients treated with lenalidomide and dexamethasone

✍ Ulrike Klein; Florentina Kosely; Jens Hillengaß; Michael Hundemer; Stefan Schmit 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 107 KB

P140 Prognostic impact of 1q21 amplifica

P140 Prognostic impact of 1q21 amplification in patients with multiple myeloma treated by velcade, thalidomide and any conventional chemotherapy

✍ P. Nemec; P. Kuglik; V. Vranova; R. Zaoralova; H. Greslikova; A. Oltova; H. Filk 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Conclusions: Among their pts with GI nHl the slow increase of incidence from all lymphoma cases, the slight decrease of MALT lymphomas, the elevation of cases of intestinal and of gastric lymphomas with high grade B-cell origin and at all, in this latter group the beneficial effect of rituximab+CHOP

Impact of high-risk cytogenetics and pri

Impact of high-risk cytogenetics and prior therapy on outcomes in patients with advanced relapsed or refractory multiple myeloma treated with lenalidomide plus dexaméthasone

✍ Avet-Loiseau, H; Soulier, J; Fermand, J-P; Yakoub-Agha, I; Attal, M; Hulin, C; G 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 313 KB

Abnormalities of chromosome 1p/q are hig

Abnormalities of chromosome 1p/q are highly associated with chromosome 13/13q deletions and are an adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma

✍ Ka Lung Wu; Berna Beverloo; Henk M. Lokhorst; Christine M. Segeren; Bronno Van D 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 553 KB

Enoxaparin or aspirin for the prevention

Enoxaparin or aspirin for the prevention of recurrent thromboembolism in newly diagnosed myeloma patients treated with melphalan and prednisone plus thalidomide or lenalidomide

✍ A. PALUMBO; C. RUS; J. B. ZELDIS; F. RODEGHIERO; M. BOCCADORO; THE ITALIAN MULTI 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

Long-term follow-up on overall survival

Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma

✍ Dimopoulos, M A; Chen, C; Spencer, A; Niesvizky, R; Attal, M; Stadtmauer, E A; P 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 164 KB